# Indaptus Therapeutics, Inc.: Form 8-K, filed Feb 14, 2023

- Company: [Indaptus Therapeutics, Inc.](/companies/indp.md) (CIK 1857044)
- Form: 8-K
- Filed: 2023-02-14
- Accepted by EDGAR: Feb 14, 2023, 08:15 ET
- Period: 2023-02-13
- Accession: 0001493152-23-004613
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1857044/000149315223004613/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1857044/000149315223004613/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1857044/000149315223004613/form8-k.htm

Filed Feb 14, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-004613. Last ingested by Listed: Nov 14, 2026, 21:10 ET. No prices; not investment advice.
